Skip to content

Home

info@nutrigenomicsinstitute.com (+34) 91 9619057
My Account
Linkedin page opens in new windowFacebook page opens in new windowInstagram page opens in new window

Instituto Nutrigenomica

Nutrigenomics Institute
Nutrigenomics and Nutrigenetics Online Courses
Nutrigenomics Institute
  • About Us
  • Our Courses
    • ONLINE COURSE ON NUTRIGENOMICS FOR PROFESSIONALS OF NUTRITION
    • ONLINE COURSE ON NUTRIGENOMICS FOR HEALTH AND SPORTS
    • ONLINE ADVANCED COURSE ON NUTRIGENETICS AND NUTRIGENOMICS FOR PROFESSIONALS OF NUTRITION
  • Teachers
    • Dr. José Serrano
    • Dr. Ana B. Granado-Serrano
    • Dr. Èlia Obis
  • Tests
  • Testimonials
  • FAQS
  • News
  • Contact
  • Account
    • My Courses
    • Login|Logout
My Account
  • About Us
  • Our Courses
    • ONLINE COURSE ON NUTRIGENOMICS FOR PROFESSIONALS OF NUTRITION
    • ONLINE COURSE ON NUTRIGENOMICS FOR HEALTH AND SPORTS
    • ONLINE ADVANCED COURSE ON NUTRIGENETICS AND NUTRIGENOMICS FOR PROFESSIONALS OF NUTRITION
  • Teachers
    • Dr. José Serrano
    • Dr. Ana B. Granado-Serrano
    • Dr. Èlia Obis
  • Tests
  • Testimonials
  • FAQS
  • News
  • Contact
  • Account
    • My Courses
    • Login|Logout

Microsomal prostaglandin E synthase-1 is involved in the metabolic and cardiovascular alterations associated with obesity

May172022

Background and Purpose

Microsomal prostaglandin E synthase-1 (mPGES-1) is an inducible isomerase responsible for prostaglandin E2 production in inflammatory conditions. We evaluated the role of mPGES-1 in the development and the metabolic and cardiovascular alterations of obesity.

Experimental Approach

mPGES-1+/+ and mPGES-1−/− mice were fed with normal or high fat diet (HFD, 60% fat). The glycaemic and lipid profile was evaluated by glucose and insulin tolerance tests and colorimetric assays. Vascular function, structure and mechanics were assessed by myography. Histological studies, q-RT-PCR, and western blot analyses were performed in adipose tissue depots and cardiovascular tissues. Gene expression in abdominal fat and perivascular adipose tissue (PVAT) from patients was correlated with vascular damage.

Key Results

Male mPGES-1−/− mice fed with HFD were protected against body weight gain and showed reduced adiposity, better glucose tolerance and insulin sensitivity, lipid levels and less white adipose tissue and PVAT inflammation and fibrosis, compared with mPGES-1+/+ mice. mPGES-1 knockdown prevented cardiomyocyte hypertrophy, cardiac fibrosis, endothelial dysfunction, aortic insulin resistance, and vascular inflammation and remodelling, induced by HFD. Obesity-induced weight gain and endothelial dysfunction of resistance arteries were ameliorated in female mPGES-1−/− mice. In humans, we found a positive correlation between mPGES-1 expression in abdominal fat and vascular remodelling, vessel stiffness, and systolic blood pressure. In human PVAT, there was a positive correlation between mPGES-1 expression and inflammatory markers.

Conclusions and Implications

mPGES-1 inhibition might be a novel therapeutic approach to the management of obesity and the associated cardiovascular and metabolic alterations.

Date: First published: 07 December 2021

Author: Constanza Ballesteros-Martínez,Raquel Rodrigues-Díez,Luis M. Beltrán,Rosa Moreno-Carriles,Ernesto Martínez-Martínez,María González-Amor,Jose Martínez-González … See all authors 

Constanza Ballesteros-Martínez and Raquel Rodrigues-Díez contributed equally to this study.

Link: Microsomal prostaglandin E synthase‐1 is involved in the metabolic and cardiovascular alterations associated with obesity – Ballesteros‐Martínez – 2022 – British Journal of Pharmacology – Wiley Online Library

https://doi.org/10.1111/bph.15776

 

Funding information: Ministerio Ciencia e Innovación. Programa Juan de la Cierva, Grant/Award Number: IJCI-2017-31399; Comunidad de Madrid, Grant/Award Number: B2017/BMD-3676 AORTASANA, FEDER-a way to build Europe; Fondo Europeo de Desarrollo Regional, Grant/Award Number: SAF2016-80305P; Ministerio de Ciencia e Innovación, Grant/Award Number: FIS PI18/0257

 

Category: NewsMay 17, 2022Leave a comment
Tags: OBESITY CARDIOVASCULAR RISKOBESITY GENE mPGES-1OBESITY GENETIC RISKOBESITY METABOLIC ALTERATIONS

RELATED POSTS

A committee of experts proposes rethinking the concept of obesity and BMI
January 20, 2025
Scientists discover a “mortality timer” in our cells
January 13, 2025
Gut microbiota: a new path to treat obesity
January 8, 2025
What are dietary exosomes and which foods include them?
December 16, 2024

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Post comment

  • A committee of experts proposes rethinking the concept of obesity and BMI
    January 20, 2025
  • Scientists discover a “mortality timer” in our cells
    January 13, 2025
  • Gut microbiota: a new path to treat obesity
    January 8, 2025
  • What are dietary exosomes and which foods include them?
    December 16, 2024
  • The yo-yo effect: Adipose tissue retains an epigenetic memory of obesity after weight loss
    December 9, 2024